Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baccide
- Development stage
- Unknown
- Lead developer
- The Cooper Companies
- Modality
- Small Molecules
01
Overview
Baccide is a line of over-the-counter (OTC) consumer health products developed and manufactured by Coopération Pharmaceutique Française (Cooper). The brand specializes in disinfectant solutions, most notably hydroalcoholic hand sanitizers and surface disinfectants. Formulated with a triple-action approach, Baccide products are bactericidal, fungicidal, and virucidal, designed to eliminate 99.9% of common pathogens including bacteria, fungi, and viruses. These products are widely utilized in both domestic and professional healthcare environments in France to maintain hygiene and prevent the spread of infectious diseases, particularly during epidemic periods.
- Brand names
- Baccide
02
Targets
Biological membrane lipid bilayer
Beyond the preview
Go deeper on Baccide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baccide.